Načítá se...
Immunotherapy of hepatocellular carcinoma with infection of hepatitis B or C virus
Hepatocellular carcinoma (HCC) has one of highest mortalities globally amongst cancers, but has limited therapeutic options once in the advanced stage. Hepatitis B or C virus infection are the most common drivers for HCC carcinogenesis, triggering chronic liver inflammation and adding to the complex...
Uloženo v:
| Vydáno v: | Hepatoma Res |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7597818/ https://ncbi.nlm.nih.gov/pubmed/33134550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/2394-5079.2020.58 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|